Advertisement

Topics

Biogen Incorporated Company Profile

12:12 EDT 26th September 2017 | BioPortfolio

Biogen, Inc. is a biopharmaceutical company principally engaged in the business of developing, manufacturing and marketing drugs for human health care. The Company currently derives revenues from sales of its AVONEX(R) (Interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis and from sales by its licensees of a number of products, including alpha interferon, hepatitis B vaccines and hepatitis B diagnostic products.

Location

14 Cambridge Center
Cambridge
MA
02142
United States of America

Contact

Phone: 617 679 2000
Fax: 617 679 2617


News Articles [290 Associated News Articles listed on BioPortfolio]

Biogen Acquires Remedy Pharmaceuticals' CIRARA™ for Large Hemispheric Stroke

Phase 3-ready program complements Biogen's ongoing development efforts in stroke Biogen will pay a $120 million upfront payment plus potential milestone and royalty payments Biogen (NASDAQ: BIIB) ...

Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & ...

BiogenMatt Fearer, +1-781-464-3260public.affairs@biogen.comorBenjamin Strain, +1-781-464-2442IR@biogen.com Read more...

Head to Head Survey: Biogen (BIIB) and Its Peers

Biogen is one of 45 public companies in the "Biopharmaceuticals" industry, but how does it contrast to its peers? We will compare Biogen to similar companies based on the strength of its analyst recom...

Biogen-Aktie: Chance/Risiko-Profil wird besser! - Aktienanalyse

Zürich - Biogen-Aktienanalyse von Analyst Carter Gould von der UBS: Laut einer Aktienanalyse vertritt der Analyst Carter Gould von der UBS im Hinblick auf die Aktien des US-Biotechkonzerns Biogen I.....

High expectations for Amy Chevalier Efantis at Biogen

US biotech major Biogen has brought in a woman with a background in both biopharma and the public sector…

Biogen, Opening Bottlenecks, Sees Spine Drug Sales, Shares Rise

Another quarter is in the books for Biogen’s nusinersen (Spinraza), the first ever approved drug for spinal muscular atrophy. And despite the drug’s high price and the logistical bottlenecks invol...

Biogen’s 2017 2nd-qtr beats forecasts but leaves investors uncertain

US biotech Biogen had an up-and-down morning in the stock market on Tuesday after announcing its results…

Samsung, Biogen version of AbbVie's Humira approved in Europe

(Reuters) - Biogen Inc's version of AbbVie Inc's blockbuster arthritis drug Humira has been approved by European Union regulators, Biogen and joint venture partner Samsung Biologics said on Thursday. ...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Biogen pays Forward in Tecfidera dispute.

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic.

The Biogen upstream platform is capable of delivering equivalent quality material throughout the cell line generation process. This allows us to rapidly deliver high quality biopharmaceuticals to pati...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

To determine the maximal safe daily dose of BG8962 (rCD4) which can be administered by continuous subcutaneous infusion (CSCI) over 24 hours; to determine the pharmacokinetics of BG8962 wh...

Safety and Tolerability of Repeat Courses of IM Alefacept

Previous Biogen studies have provided experience with the tolerability, immunogenicity, and efficacy of a single and multiple 12-week courses of therapy of alefacept. At this stage, experi...

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

The purpose of this study is to see if we can find a new way to test how certain Multiple Sclerosis (MS) medications work in the body and to better understand how the medicines change cert...

Pregnancy Exposure Registry for AVONEX

This is an observational, exposure-registration and follow-up study, which will be conducted in the United States (US). The AVONEX® Pregnancy Exposure Registry is designed to monitor pre...

Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy

Study phase: Phase II Investigational product, dosage, and route of administration: Ibritumomab tiuxetan ("Zevalin) is composed of a murine IgG1 monoclonal antibody (ibritumomab) covalentl...

Companies [64 Associated Companies listed on BioPortfolio]

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec and Elan Corporation, plc

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Inc.

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hema...

Biogen Idec and Abbott

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

More Information about "Biogen Incorporated" on BioPortfolio

We have published hundreds of Biogen Incorporated news stories on BioPortfolio along with dozens of Biogen Incorporated Clinical Trials and PubMed Articles about Biogen Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biogen Incorporated Companies in our database. You can also find out about relevant Biogen Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record